neuromodulation

Nervonik, Inc., a medical technology company developing a next-generation peripheral nerve stimulation platform for chronic pain, today announced it is expanding its leadership team with the addition of several experienced medical device and neuromodulation leaders - Rob DiTota, Dan Brounstein, and Patrick Martin - as the company moves toward its planned 510(k) submission and commercial launch.

BackgroundSpinal cord injury (SCI) affects 15.4 million people worldwide, with a substantial proportion of incomplete SCI patients remaining non-ambulatory, highlighting the importance of motor function recovery and mobility in rehabilitation. While transcutaneous spinal cord stimulation (tSCS) has emerged as a promising non-invasive neuromodulation technique for enhancing motor recovery, the the…

ROCHESTER, Minn. — Mayo Clinic researchers have created a detailed map of the pulvinar, a deep brain region that could help doctors more precisely target brain stimulation therapies for people with drug-resistant epilepsy. The findings, published in the Journal of Neuroscience, reveal that brain regions separated by only a few millimeters connect to entirely different

Auricular vagus nerve stimulation (aVNS) is a neuromodulation technology that establishes balance in the autonomic nervous system and, in turn, provides therapy for numerous chronic ailments. Personalized aVNS adapts the stimulation parameters in accordance with the time-varying physiological state of the body, and is suggested to improve the therapeutic outcomes and reduce side effects. The phys…

Major depressive disorder (MDD) remains one of the leading causes of disability worldwide, with nearly 200 million people affected. While many respond well to antidepressants, psychotherapy, or neuromodulation approaches like TMS and ECT, up to 40% of patients experience little... The post Deep Brain Stimulation Offers New Hope for Treatment-Resistant Depression appeared first on Louis A. Faillac…

Dr. Xiang Qian and Dr. QiLiang Chen demonstrate the feasibility of a minimally invasive PNS technique that provides reduction in headache pain for a sustained time, even after the device is removed.

In this episode, Dr. Stavros Zanos, a renowned researcher at the Feinstein Institutes for Medical Research, discusses the potential of focused ultrasound neuromodulation in treating a wide range of cardiovascular and inflammatory diseases. Dr. Zanos explains how ultrasound activates neurons through mechanosensitive channels and shares the promising results of recent studies using neuromodulation …

Congratulations to BioE PhD alumna Kate Rosenbluth, founder of Cala Health, named to Forbes' list of "52 Women-Led Startups Driving The Future Of HealthTech And FemTech". Cala Health creates non-invasive wearable neuromodulation therapies for patients living with chronic diseases.